Connect with us

Technology

Leveraging EMR/EHR Data and Patient Engagement to Maximize Clinical Trial Recruitment, Upcoming Webinar Hosted by Xtalks

Published

on

In this free webinar, learn how to maximize clinical trial recruitment through electronic medical record (EMR) data and personalized engagement. Attendees will learn how current limitations within research sites and the trial process hinder effective patient recruitment and enrollment efforts. The featured speakers will discuss how, despite privacy and security concerns, EMR queries can revolutionize how we recruit, engage and enroll participants in clinical trials. The speakers will also share how meaningful conversations and tailored education are key to helping participants understand trial benefits and make informed decisions about enrollment. Attendees will learn how leveraging new data, technology and services offers practical ways to overcome longstanding issues in clinical research recruitment and engagement.

TORONTO, Oct. 29, 2024 /PRNewswire-PRWeb/ — Maximizing Recruitment Through EMR Data and Personalized Engagement

An important piece is the human touch — the conversations that help patients understand how clinical research might benefit them personally or serve the greater good for others living with similar conditions.

One of the core challenges in clinical research is recruiting the right participants. Various outreach methods, including recruitment advertising and physician referrals, are critical but often insufficient in isolation. This is where integrating electronic medical record (EMR) queries comes into play. EMR queries can be a great starting point for identifying suitable participants, and when followed by meaningful engagement, enrollment can be achieved more effectively.

While it is well known that EMR/electronic health record (EHR) data can match patients to clinical trials, data alone does not close the gap. An important piece is the human touch — the conversations that help patients understand how clinical research might benefit them personally or serve the greater good for others living with similar conditions.

In this webinar, the expert speakers discuss patient identification and the steps that follow in the participant journey to ensure researchers are meeting enrollment goals in clinical trials. The panel provides their perspectives on the barriers across clinical research sites and throughout the trial process while discussing how patient EMR data can effectively address these challenges. Additionally, they will explore the various data, technology and services that can create actionable solutions, including the implications of consolidation within the patient EMR space and its significance for pharmaceutical sponsors.

This webinar will be advantageous for those interested in learning more about the potential of EMR/EHR data throughout the clinical research process, who want to hear first-hand insights from leaders throughout the pharmaceutical industry or who wish to gain a better understanding of how we can all work together to solve the historical issues surrounding research engagement and the cutting-edge applications of healthcare data as part of the solution.

Register for this webinar today to discover how integrating EMR data with personalized patient engagement strategies can transform recruitment in clinical trials.

Join Irfan Khan (Moderator), MD, CEO, Circuit Clinical; Kelly McKee, Head of Innovative Patient Recruitment, Evinova, AstraZeneca; Scott Gucciardi, SVP/GM, Connectivity, Insights, and VBC Businesses, NextGen Healthcare; Meghna Wolfe, Manager of Business Partner Relations, NextGen Healthcare; and Kathy Bean, RHIA, CHPS, Vice President of Technology & Clinical Informatics, Circuit Clinical, for the live webinar on Tuesday, November 19, 2024, at 2pm EST (11am PST).

For more information, or to register for this event, visit Leveraging EMR/EHR Data and Patient Engagement to Maximize Clinical Trial Recruitment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/leveraging-emrehr-data-and-patient-engagement-to-maximize-clinical-trial-recruitment-upcoming-webinar-hosted-by-xtalks-302290184.html

SOURCE Xtalks

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Hot from Hong Kong Fintech Week 2024: AI’s Role in Transforming Insurance

Published

on

By

SINGAPORE, Oct. 30, 2024 /PRNewswire/ — At the 2024 Hong Kong FinTech Week InsurTech Forum, Charles Hung, CEO of Blue Insurance; Gilbert Leung, CEO of Novo AI; and Priscilla Ng, Prudential’s Group Chief Customer & Marketing Officer explored the transformative role of AI in the insurance sector. The discussion centered around AI’s ability to enhance customer experience, improve operational efficiency, and navigate industry-specific challenges.

Applications and Challenges of AI in Insurance

Priscilla Ng highlighted that Prudential uses AI to sift through vast volumes of customer feedback, allowing teams to address issues efficiently and improve customer engagement. Charles Hung of Blue Insurance emphasized AI’s power in providing personalized and consistent service, helping meet customer expectations at scale. Gilbert Leung from Novo AI discussed the importance of AI in fraud detection and cost control, crucial for managing escalating expenses and protecting bottom line.

However, challenges in implementing AI persist across the industry. For Prudential, data quality and prioritizing use cases are key considerations, while Blue Insurance pointed out the difficulties in sourcing skilled talent and having accurate data. Novo AI noted the rapid pace of AI development, making fast iterations and keeping up to speed with model enhancements are essential to long term success. These insights underscore the need for deliberate, well-structured strategies tailored to tackling insurance’s unique challenges.

Ensuring Fairness and Accuracy with “Humans in the Loop”

A key theme throughout the discussion was the necessity of human oversight in AI to maintain fairness and accuracy. Gilbert Leung emphasized the importance of human expertise is integral at each stage of AI operations, ensuring that AI systems are designed with diligence, reducing biases and upholding ethical standards. Particularly in fields like healthcare, where AI-driven decisions impact sensitive human outcomes, this level of human judgment is essential for building trust and accountability.

AI as an Essential Tool for the Future of Insurance

Last but not least, the discussion ended with a mutual agreement that AI has progressed beyond being a competitive advantage to a survival kit. With its ability to streamline claims handling, enhance transparency, fight fraud and abuse, AI is reshaping insurance operations like never before. Meanwhile, human oversight remains indispensable to ensure that AI-driven decisions reflect both care and ethical integrity. This balanced approach to integrating AI sets a responsible path forward, allowing insurers to harness AI’s potential while maintaining customer trust.

For more info: partnerships@heynovo.ai 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/hot-from-hong-kong-fintech-week-2024-ais-role-in-transforming-insurance-302290275.html

SOURCE Novo AI

Continue Reading

Technology

Validation Cloud Secures $10M Lead to Scale AI for Web3 from True Global Ventures

Published

on

By

ZUG, Switzerland, Oct. 30, 2024 /PRNewswire/ — Validation Cloud, the leading Web3 data and AI company, has selected True Global Ventures as its lead investor, contributing $10M. The company plans to use the funds to expand its AI product, bringing seamless access to Web3 data and enabling unparalleled user experiences in network ecosystems and applications.

“Web3 needs seamless access to data to reach a billion users; Validation Cloud is solving this critical hurdle to adoption through technological breakthroughs in its core platform alongside AI. We have seen staking and node API services, but never in combination with AI. This is what we are most excited about with Validation Cloud’s data product offering for Web3 infrastructure companies,” said Beatrice Lion, CEO & General Partner of True Global Ventures.

The company’s product platform comprises three components: staking, node API, and data & AI. In staking, Validation Cloud has exceeded more than $1 billion of assets staked, growing 400% year-over-year. Further, its Node API consistently demonstrates the best global performance, measured by CompareNodes. Some of Validation Cloud’s clients include Chainlink, Aptos, Consensys, Stellar, and Hedera.

Most notably, its AI platform makes on-chain data exploration easier and faster. Validation Cloud’s platform drives greater engagement by compressing navigation from hours to seconds, resulting in a larger, more active user base. This innovation represents a distinctive step in making blockchain data more accessible.

“We are thrilled to partner with True Global Ventures due to their global commercial reach, focus on the intersection of Web3 and AI, and synergistic portfolio. TGV has a deep alignment with our mission and exceptional value-add beyond their capital,” said Alex Nwaka, Co-Founder of Validation Cloud.

“We see the future of Web3 being shaped by the combination of AI and infrastructure. Validation Cloud’s focus on making data more accessible is exactly what the industry needs to scale,” said Aly Madhavji, Managing Partner of Blockchain Founders Fund.

Validation Cloud is one of the fastest-growing companies in Web3. This funding round follows the company’s raise in February 2024, led by San Francisco-based Cadenza Ventures, with participation from Blockwall, Bloccelerate, Side Door Ventures, GS Futures, AP Capital, Blockchain Founders Fund, and Metamatic.

About Validation Cloud

Validation Cloud is a Web3 data and AI company with industry-leading products in staking, node, and data-as-a-service. Validation Cloud is trusted by the top networks, applications, and enterprises in Web3, demanding #1 performance, scalability, and SOC2 Type 2 compliance.

Learn more at Validationcloud.io | LinkedIn | X  | Podcast

About True Global Ventures, TGV

TGV 4 Plus Fund invests in AI and blockchain-driven companies globally. TGV backs visionary entrepreneurs in sectors including AI, entertainment, technology infrastructure, and financial services in the early stages and beyond Series B.

View original content:https://www.prnewswire.com/apac/news-releases/validation-cloud-secures-10m-lead-to-scale-ai-for-web3-from-true-global-ventures-302289919.html

SOURCE Validation Cloud

Continue Reading

Technology

Getac Integrates Sony Semiconductor Solutions’ SORPLAS™ Environmentally Conscious Plastic into its Range of Premium Rugged Products

Published

on

By

News in brief:

Getac aims to take a new step towards a sustainable world by adopting SORPLAS™ from Sony Semiconductor Solutions (SSS) in its Premium Rugged Products, beginning with the recently launched S510 rugged laptop and K120 fully rugged tablet.SORPLAS is an environmentally conscious plastic developed and provided by SSS, which can achieve up to 99% utilisation rate of recycled materials.The announcement reaffirms Getac’s collaboration with SSS to delivering long-term sustainability in the technology manufacturing industry

TAIPEI, Oct. 30, 2024 /PRNewswire/ — Getac Technology Corporation (Getac) today announced a new step towards a sustainable world by adopting SSS’ innovative SORPLAS into its range of premium rugged laptops and tablets. The announcement reaffirms both companies’ collaboration to utilising environmentally conscious materials and developing products that create a more sustainable future for all.

SORPLAS is an environmentally conscious plastic developed and provided by SSS, which can achieve up to 99% utilisation rate of recycled materials. SORPLAS is incredibly durable, even in high-temperatures and humid environments where plastics can quickly deteriorate, and it also gives consideration to aesthetics. Thanks to the above-mentioned high-quality standards and environmental friendliness, SORPLAS is used in Sony Group’s products, as well as outside Sony Group companies.

In addition, compared to virgin flame-retardant polycarbonate resin, the amount of CO2 emitted during SORPLAS production is significantly reduced, and it has been technically confirmed that its properties can be maintained even after repeated recycling.  As a result, its adoption can greatly reduce the environmental impact of technology manufacturing in the future.

Getac’s goal is to harness technology wherever possible to fulfil its commitment to the environment. A key part of this has been steadily increasing the use of PCR (Post-Consumer Recycled) materials during the development phase of new products. The first integration of SORPLAS into its premium range of products came with the launch of the S510, the world’s first AI-ready rugged laptop, followed by the highly versatile next generation K120 fully rugged tablet. The successful adoption of PCR materials underscores Getac’s dedication to delivering environmentally friendly products while maintaining the high levels of reliability and performance demanded by customers across the rugged industries.

“The technology industry has a collective responsibility to protect our planet for future generations,” says Eita Yanagisawa, Senior General Manager of Sony Semiconductor Solutions Corporation. “SORPLAS embodies our commitment to fulfilling this responsibility, utilising cutting-edge recycling technology to achieve an exceptionally high utilisation rate of recycled materials. It is already used extensively in Sony Group’s products, and we’re excited to bring it to a wider audience through partnerships with other environmentally conscious companies like Getac.”

“Getac is firmly committed to creating a more sustainable future through environmentally responsible design and manufacturing, and we actively pursue innovation that enables us to achieve our goal,” says James Hwang, President of Getac Technology Corporation. “Implementing SORPLAS into our rugged devices is the latest step on this path and we look forward to working closely with Sony Semiconductor Solutions to bring it to more of our products and solutions going forward, helping to safeguard the future of our planet for future generations.”

About Getac

Getac Technology Corporation is a global leader in rugged mobile technology and intelligent video solutions, including laptops, tablets, software, body-worn cameras, in-car video systems, digital evidence management and enterprise video analytics solutions. Getac’s solutions and services are designed to enable extraordinary experiences for frontline workers in challenging environments. Today, Getac serves customers in over 100 countries spanning defence, public safety, ambulance, fire & rescue, utilities, automotive, natural resources, manufacturing, transport, and logistics. For more information, visit: http://www.getac.com. Participate in the Getac Industry blog or follow the company on LinkedIn and YouTube.

Getac and Getac logo are trademarks of Getac Holdings Corporation or its affiliates. Other brands or trademarks are the property of their respective owners. ©2024 Getac Technology Corporation.

“SORPLAS” is a trademark of Sony Group Corporation.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/getac-integrates-sony-semiconductor-solutions-sorplas-environmentally-conscious-plastic-into-its-range-of-premium-rugged-products-302288376.html

SOURCE Getac

Continue Reading

Trending